PSTV

PLUS THERAPEUTICS, Inc.

2.25 USD
+0.01 (+0.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PLUS THERAPEUTICS, Inc. stock is up 38.04% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.38% of the previous 20 May’s closed higher than April.

About PLUS THERAPEUTICS, Inc.

Plus Therapeutics, Inc. focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma.